Skip to main content
Caplight Logo









ACCRX, Inc.

ACCRX, Inc.

Private
Newton, MassachusettsHealthcare & Life Scienceshttps://www.accrx.com/

Last Round

Series B

Sep 15, 2021

Est. Valuation

$285,000

Total Funding Raised

$49.52M

Company Overview

ACCRX, Inc. is a pharmacy company that provides custom-made compounding services for patients, doctors, hospitals, and veterinarians.

Sector

Healthcare & Life Sciences

Verticals

Patient Engagement, Telemedicine, EHR & EMR, Vertical SaaS, NLP & Conversational AI

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Keywords

patient communicationelectronic health recordEHRpatient engagementtelemedicineclinical softwaredigital healthhealthtechappointment schedulingpatient triagevertical SaaSambient scribingAI scribeclinical workflowNHS software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ACCRX, Inc. Comparables

Compare ACCRX, Inc. with similar companies based on industry and business-model similarity.

ACCRX, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Anima
86%
Silicon Practice
85%
iPLATO Healthcare
85%

ACCRX, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BSep 15, 2021
Series AFeb 24, 2019
AcceleratorSep 6, 2016

ACCRX, Inc. Investors

Notable investors and investment history

ACCRX, Inc. investors
InvestorRounds
Encore CapitalSeries B
LakestarSeries B
British Patient CapitalSeries B
Phoenix Court GroupSeries A
AtomicoSeries B, Series A
LatitudeSeries B
Entrepreneurs FirstSeries A, Accelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 6, 2016

    $23K round led by Entrepreneurs First

ACCRX, Inc. Filings

Explore SEC and related filing metadata, where available.

ACCRX, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about ACCRX, Inc.'s valuation, stock price, and market status.

Is ACCRX, Inc. a public or private company?

ACCRX, Inc. is a private company.

What is the current stock price of ACCRX, Inc.?

ACCRX, Inc. is a private company with no public stock price. Caplight tracks ACCRX, Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is ACCRX, Inc. worth (valuation)?

ACCRX, Inc.'s valuation is estimated at $285.0K based on funding round data.

Can I buy ACCRX, Inc. stock?

ACCRX, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was ACCRX, Inc.'s last funding round?

ACCRX, Inc.'s most recent funding round was Series B on September 6, 2016.

Who are the main investors in ACCRX, Inc.?

Key investors in ACCRX, Inc. include Lakestar, Atomico, Entrepreneurs First.

Will ACCRX, Inc. IPO soon?

No public IPO plans have been announced for ACCRX, Inc..

How can I track ACCRX, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ACCRX, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNewton, Massachusetts
Year Founded2003
Last FundingSep 15, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?